Treatment of skull base tumors

Current Opinion in Oncology

Volumn 15, Issue 3, 2003, Pages 209-212

  Prabhu, Sujit S ^a   Demonte, Franco ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; HYDROXYUREA;

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CAVERNOUS SINUS; CHONDROMA; CHONDROSARCOMA; FUTUROLOGY; GENE TARGETING; GENE THERAPY; HORMONAL THERAPY; HUMAN; MENINGIOMA; NEURILEMOMA; PARAGANGLIOMA; POSTERIOR FOSSA; PRIORITY JOURNAL; RADIOSURGERY; REVIEW; SKULL BASE TUMOR; STATISTICAL SIGNIFICANCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMANS; IMMUNOTHERAPY; MALE; MENINGIOMA; NEOPLASM STAGING; NEURILEMMOMA; NEUROSURGERY; PROGNOSIS; RADIOSURGERY; RADIOTHERAPY, HIGH-ENERGY; RISK ASSESSMENT; SKULL BASE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0038686980     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200305000-00005     Document Type: Review

References (19)

1. Rosen CL, Ammerman JM, Sekhar LN: Bank WO. Outcome analysis of preoperative embolization in cranial base surgery. Acta Neurochir (Wien) 2002, 144:1157-1164.
2. Cho CW, Al-Mefty O: Combined petrosal approach to petroclival meningiomas. Neurosurgery 2002, 51:708-716; discussion 716-718.
3. Iwai Y, Yamanaka K, Nakajima H: The treatment of skull base meningiomas-combining surgery and radiosurgery. J Clin Neurosci 2001, 8:528-533.
4. Black PM, Villavicencio AT, Rhouddou C, et al.: Aggressive surgery and focal radiation in the management of meningiomas of the skull base: preservation of function with maintenance of local control. Acta Neurochir (Wien) 2001, 143:555-562.
5. Mason WP, Gentili F, Macdonald DR, et al.: Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg 2002, 97:341-346.
6. Dirven CM, Grill J, Lamfers ML, et al.: Gene therapy for meningioma: improved gene delivery with targeted adenoviruses. J Neurosurg 2002, 97:441-449.
7. Karpinos M, Teh BS, Zeck O, et al.: Treatment of acoustic neuroma: stereotactic radiosurgery vs. microsurgery. Int J Radiat Oncol Biol Phys 2002, 54:1410-1421.
8. Moriyama T, Fukushima T, Asaoka K, et al.: Hearing preservation in acoustic neuroma surgery: importance of adhesion between the cochlear nerve and the tumor. J Neurosurg 2002, 97:337-340.
9. Subach BR, Kondziolka D, Lunsford LD, et al.: Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2. J Neurosurg 1999, 90:815-822.
10. Ho SY, Kveton JF: Rapid growth of acoustic neuromas after stereotactic radiotherapy in type 2 neurofibromatosis. Ear Nose Throat J 2002, 81:831-833.
11. Tago M, Terahara A, Nakagawa K, et al.: Immediate neurological deterioration after gamma knife radiosurgery for acoustic neuroma. Case report. J Neurosurg 2000, 93(Suppl 3):78-81.
12. Noel G, Habrand JL, Mammar H, et al.: Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protontherapie D'Orsay experience. Int J Radiat Oncol Biol Phys 2001, 51:392-398.
13. Deniz ML, Kilic T, Almaata I et al.: Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence. Neurosurgery 2002, 51:753-760; discussion 760.
14. Scheil S, Bruderlein S, Liehr T, et al.: Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 2001, 32:203-211.
15. Al-Mefty O, Teixeira A: Complex tumors of the glomus jugulare: criteria, treatment, and outcome. J Neurosurg 2002, 97:1356-1366.
16. Dulguerov P, Jacobsen MS, Allal AS, et al.: Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001, 92:3012-3029.
17. Chang DW, Langstein HN, Gupta A, et al.: Reconstructive management of cranial base defects after tumor ablation. Plast Reconstr Surg 2001, 107:1346-1355; discussion 1356-1357.
18. DeMonte F: Functional outcomes in skull base surgery. What is acceptable? Clin Neurosurg 2001, 48:340-350.
19. Kelleher MO, Fernandes MF, Sim DW, et al.: Health-related quality of life in patients with skull base tumours. Br J Neurosurg 2002, 16:16-20.